A Perspective article in Nature describes the functional organization of a large collaborative research program, SAVE, designed to rapidly identify emerging SARS-CoV-2 variants that might pose an elevated threat to human health
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.The global emergence of many severe acute respiratory syndrome coronavirus 2 variants jeopardizes the protective antiviral immunity induced following infection or vaccination.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USAThe Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USAGlobal Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Genetics and Genomic Sciences, Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USADepartment of Epidemiology,...
Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, JapanDisease Control and Prevention Center, National Center for Global Health and Medicine Hospital, Tokyo, JapanDepartment of Infectious Diseases, St.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Genome data gaps could stymie search for next COVID variantSequencing SARS-CoV-2 genomes has helped researchers to track how the virus is evolving, but many countries aren’t sharing all their data.
Read more »
Diabetes risk rises after COVID, massive study findsEven mild SARS-CoV-2 infections can amplify a person’s chance of developing diabetes, especially for those already susceptible to the disease.
Read more »
Omicron sub-variant BA.2 accounts for about 55% of COVID variants in U.S. - CDCThe U.S. national public health agency said on Tuesday that BA.2 sub-variant of Omicron was estimated to account for more than half the coronavirus variants in the country.
Read more »
More People Are Now Eligible for a Fourth COVID VaccineFor now, fourth COVID vaccine only needed for immunocompromised, including people with cancer, immune deficiency, or those on immune-suppressive meds.
Read more »
Obesity alters pathology and treatment response in inflammatory disease - NatureObesity changes the characteristics of the immune response induced in a mouse model of atopic dermatitis, suggesting therapies that could be used against immune dysregulation in obesity.
Read more »